1-8 of 8
Hiroyuki Tsunoda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6145: Increased PD-L1 expression levels were observed on both tumor cells and macrophages by tocilizumab plus gemcitabine/nab-paclitaxel treatment in gemcitabine/nab-paclitaxel-refractory metastatic pancreatic cancer patients

Free
Kyoko Yamaguchi, Etsuko Fujii, Shuichi Mitsunaga, Noriaki Sawada, Masafumi Ikeda, Takashi Fujitomo, Hideaki Mizuno, Yoko Kayukawa, Mayu Makikawa, Kazunori Aoki, Hiroshi Imaoka, Mitsuhito Sasaki, Kazuo Watanabe, Atsukiko Kato, Hiroyuki Tsunoda, Kimio Terao, Atsushi Ochiai
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6145.
https://doi.org/10.1158/1538-7445.AM2022-6145
Published: 15 June 2022
View articletitled, Abstract 6145: Increased PD-L1 expression levels were observed on both tumor cells and macrophages by tocilizumab plus gemcitabine/nab-paclitaxel treatment in gemcitabine/nab-paclitaxel-refractory metastatic pancreatic cancer patients
Journal Articles

Abstract CT565: Clinical and translational results of a phase I study, tocilizumab plus gemcitabine/nab-paclitaxel in patient with gemcitabine/nab-paclitaxel-refractory metastatic pancreatic cancer

Free
Shuichi Mitsunaga, Masafumi Ikeda, Kazunori Aoki, Kyoko Yamaguchi, Noriaki Sawada, Etsuko Fujii, Masanobu Nishidate, Takashi Fujitomo, Hideaki Mizuno, Yoko Kayukawa, Atsuhiko Kato, Mayu Makikawa, Hiroshi Imaoka, Mitsuhito Sasaki, Kazuo Watanabe, Hiroyuki Tsunoda, Kimio Terao, Atsushi Ochiai
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT565.
https://doi.org/10.1158/1538-7445.AM2022-CT565
Published: 15 June 2022
View articletitled, Abstract CT565: Clinical and translational results of a phase I study, tocilizumab plus gemcitabine/nab-paclitaxel in patient with gemcitabine/nab-paclitaxel-refractory metastatic pancreatic cancer
Journal Articles

Abstract 1886: Anti -GPRC5D/CD3 T cell-redirecting bispecific antibody with potent in vitro and in vivo antitumor efficacy against multiple myeloma

Free
Tatsushi Kodama, Yu Kochi, Waka Nakai, Hideaki Mizuno, Takeshi Baba, Kiyoshi Habu, Noriaki Sawada, Hiroyuki Tsunoda, Takahiro Shima, Kohta Miyawaki, Yoshikane Kikushige, Yasuo Mori, Toshihiro Miyamoto, Takahiro Maeda, Koichi Akashi
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1886.
https://doi.org/10.1158/1538-7445.AM2021-1886
Published: 01 July 2021
View articletitled, Abstract 1886: Anti -GPRC5D/CD3 T cell-redirecting bispecific antibody with potent in vitro and in vivo antitumor efficacy against multiple myeloma
Journal Articles

Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer

Free
Takahiro Ishiguro, Yasuko Kinoshita, Masamichi Sugimoto, Yoko Miyazaki, Atsuhiko Kato, Kiyotaka Nakano, Hirotake Takai, Hiroyuki Tsunoda, Izumi Sugo, Iwao Ohizumi, Hiroyuki Aburatani, Takao Hamakubo, Tatsuhiko Kodama, Masayuki Tsuchiya, Hisafumi Yamada Okabe
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2426.
https://doi.org/10.1158/1538-7445.AM10-2426
Published: 15 April 2010
View articletitled, Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer
Journal Articles

Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer

Free
Takahiro Ishiguro, Masamichi Sugimoto, Yasuko Kinoshita, Yoko Miyazaki, Kiyotaka Nakano, Hiroyuki Tsunoda, Izumi Sugo, Iwao Ohizumi, Hiroyuki Aburatani, Takao Hamakubo, Tatsuhiko Kodama, Masayuki Tsuchiya, Hisafumi Yamada-Okabe
Journal: Cancer Research
Cancer Res (2008) 68 (23): 9832–9838.
https://doi.org/10.1158/0008-5472.CAN-08-1973
Published: 01 December 2008
View articletitled, Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
Open the PDF for Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer in another window
Journal Articles

Recombinant human hexamer-dominant IgM monoclonal antibody to Ganglioside GM3 for treatment of melanoma

Free
Yumiko Azuma, Yuji Ishikawa, Shigeto Kawai, Toshiaki Tsunenari, Hiroyuki Tsunoda, Tomoyuki Igawa, Shin-ichiro Iida, Masahiko Nanami, Masami Suzuki, Reiko Irie, Masayuki Tsuchiya, Hisafumi Yamada-Okabe
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2406.
Published: 01 May 2008
View articletitled, Recombinant human hexamer-dominant IgM monoclonal antibody to Ganglioside GM3 for treatment of melanoma
Journal Articles

A new methodology of isolation of colonocytes in naturally evacuated feces and its clinical application in colorectal cancer diagnosis.

Free
Hisayuki Matsushita, Yasuhiro Matsumura, Yoshihiro Moriya, Takayuki Akasu, Shin Fujita, Seiichiro Yamamoto, Shigeki Ito, Norio Saito, Masanori Sugito, Masaaki Ito, Takahiro Kozu, Takashi Minowa, Sayuri Nomura, Hiroyuki Tsunoda, Tadao Kakizoe
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 98.
Published: 01 May 2005
View articletitled, A new methodology of isolation of colonocytes in naturally evacuated feces and its clinical application in colorectal cancer diagnosis.
Journal Articles

Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

Free
Yoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe, Yutaka Midorikawa, Shogo Yamamoto, Sigeo Ihara, Susumu Tokita, Hiroko Iwanari, Yukio Ito, Kiyotaka Nakano, Jun-ichi Nezu, Hiroyuki Tsunoda, Takeshi Yoshino, Iwao Ohizumi, Masayuki Tsuchiya, Shin Ohnishi, Masatoshi Makuuchi, Takao Hamakubo, Tatsuhiko Kodama, Hiroyuki Aburatani
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2418–2423.
https://doi.org/10.1158/0008-5472.CAN-03-2191
Published: 01 April 2004
View articletitled, Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma
Open the PDF for Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma in another window